Relationship between cytokine concentration in serum and preovulatory follicular fluid and in vitro fertilization/intracytoplasmic sperm injection outcome

Chemical Immunology and Allergy

Volumn 88, Issue , 2005, Pages 80-97

  Hammadeh, Mohamad Eid ^a   Fischer Hammadeh, Constanze ^a   Amer, Ahmed Samy ^a   Rosenbaum, Peter ^a   Schmidt, Werner ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLONY STIMULATING FACTOR 1; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; LEUKEMIA INHIBITORY FACTOR; SOMATOMEDIN; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

BLASTOCYST; CELL FUNCTION; EMBRYO DEVELOPMENT; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; NEUTROPHIL; NIDATION; OOCYTE; OOCYTE MATURATION; OVARY FOLLICLE CELL; OVARY FOLLICLE FLUID; OVARY FUNCTION; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW;

ANIMALS; CYTOKINES; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR FLUID; GROWTH SUBSTANCES; HUMANS; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME;

EID: 30744454576     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000087822     Document Type: Review

References (157)

1. Robertson SA, Brännström M, Seamark RF: Cytokines in the rodent reproductive and the cytokine-endocrine interaction. Curr Opin Immunol 1992;4:585-590.
2. Adashi EY: The potential relevance of cytokines to o varian physiology: The emerging role of resident ovarian cells of the white blood cell series. Endocrinol Rev 1990;11:454-464.
3. Wang LJ, Pascoe V, Petrucco OM, et al: Distribution of leukocyte subpopulations in the human corpus luteum. Hum Reprod 1992;7:197-202.
4. Brännström M, Pascoe V, Norman RJ, et al: Localization of leukocyte subsets in the follicle wall and in the corpus luteum throughout the human menstrual cycle. Fertil Steril 1994;61:488-495.
5. Loukides JA, Loy RA, Edwards R, et al: Human follicular fluids contain tissue macrophages. J Clin Endocrinol Metab 1990;71:1363-1367.
6. Harkin DG, Bignold LP, Herriot-Warnes DM, Kirby CA: Chemotaxis of polymorphonuclear leucocytes towards human pre-ovulatory follicle fluid and serum using a 'sparse-pore' polycarbonate filtration membrane. J Reprod Immunol 1994;27:151-155.
7. Herriot DM, Warnes GM, Kerin JE: Pregnancy-related chemotactic activity of human follicular fluid. Fertil Steril 1986;45:196-201.
8. Adashi EY: Intraovarian peptide. Endocriol Metab North Am 1992;21:1-17.
9. Brännström M, Norman RJ: Involvement of leukocytes and cytokines in the ovulatory process and corpus luteum function. Hum Reprod 1993;8:1762-1775.
10. Fakih H, Vijayakumar R: Improved pregnancy rates and outcome with gamete intrafallopian transfer when follicular fluid is used as a sperm capacitation and gamete transfer medium. Fertil Steril 1990;53:515-520.
11. Hemmings R, Lachapelle MH, Falcone T, et al: Effect of follicular fluid supplementation on the in vitro development of human pre-embryos. Fertil Steril 1994;62:1018-1021.
12. Adashi EY: The intraovarian insulin-like growth factor system; in Adash EY, Leung PCK (eds): The Ovary. New York, Raven Press, 1993, pp 319-336.
13. Roche JF: Control and regulation of folliculogenesis - a symposium in perspective. J Reprod Fertil 1996;1:19-27.
14. Ackland JF, Schwarz NB, Mayo KE, Dodson RE: Nonsteroidal signals originating in the gonads. Physiol Rev 1992;762:731-787.
15. Leung PCK, Steele GL: Intracellular signalling in the gonads. Endocr Rev 1992;13:476-497.
16. Pampfer S, Arceci RJ, Pollard JW: Role of colony stimulating factor-1 (CSF-1) and other lymphohematopoietic growth factors in mouse pre-implantation development. Bioessays 1991;13:535-540.
17. Tabibzadeh S: Human endometrium: An active site of cytokines production and action. Endocr Rev 1991;12:272-290.
18. Simon C, Mercader A, Frances A, et al: Hormonal regulation of serum and endometrial IL-1 alpha, IL-1 beta and IL-1ra: IL-1 endometrial microenvironment of the human embryo at the apposition phase under physiological and supraphysiological steroid level conditions. J Reprod Immunol 1996;31:165-184.
19. Giudice LC, Irwin JC: Roles of the insulin-like growth factor family in nonpregnant human endometrium and at the decidual:trophoblast interface. Semin Reprod Endocrinol 1999;17:13-21.
20. Cohen PE, Zhu L, Pollard JW: Absence of colony stimulating factor-1 in osteopetrotic (csfmop/csfmop) mice disrupts estrous cycles and ovulation. Biol Reprod 1997;56:110-118.
21. Slowey MJ, Verhage HG, Fazleabas AT: Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor localization in the baboon (Papio anubis) uterus during the menstrual cycle and early pregnancy. J Soc Gynecol Investig 1994;1:277-284.
22. Godkin JD, Dore JJ: Transforming growth factor beta and the endometrium. Rev Reprod 1998;3:1-6.
23. Cullinan EB, Abbondanzo SJ, Anderson PS, et al: Leukaemia inhibitory factor and LIF receptor expression in human endometrium suggest a potential autocrine/paracrine function in regulating embryo implantation. Proc Natl Acad Sci USA 1996;93:3115.
24. Carson D, Bagchi I, Dey S, Enders E, Fazleabas A, Lessy B, Yoshinaga K: Embryo implantation. Dev Biol 2000;223:217-237.
25. Giudice LC, Saleh W: Growth factors in reproduction. Trends Endocrinol Metab 1994;6:60-69.
26. Salamonsen LA, Dimitriadis E, Robb L: Cytokines in implantation. Semin Reprod Med 2000;18:299-310.
27. Lim H, Song H, Paria BC, Rees J, Das SK, Dey SK: Molecules in blastocyst implantation: Uterine and embryonic perspectives. Vitam Horm 2002;64:43-76.
28. Simon C, Martin JC, Meseguer M, Caballero-Campo P, Valbuena D, Pellicer A: Embryonic regulation of endometrial molecules in human implantation. J Reprod Fertil Suppl 2000;55:43-53.
29. Formby B: Immunologic response in pregnancy. Its role in endocrine disorders of pregnancy and influence on the course of maternal autoimmune diseases. Endocrinol Metab Clin North Am 1995;24:187-205.
30. Wegman TG, Lin H, Guilbert L, et al: Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon? Immunol Today 1993;14:353-356.
31. Lackey BR, Gray SL, Henricks DM: The insulin-like growth factor (IGF) system and gonadotrophin regulation: Action and interactions. Cytokine Growth Factor Rev 1999;10:201-217.
32. Monget P, Besnard N, Huet C, Pisselet C, Monniaux D: Insulin-like growth factor-binding protein and ovarian folliculogenesis. Horm Res 1996;45:211-217.
33. Jimena P, Castilla JA, Peran F, Molina R, et al: Insulin and insulin-like growth factor I in follicular fluid after induction of ovulation in women undergoing in vitro fertilization. J Reprod Fertil 1992;96:641-647.
34. Aritini PG, Battaglia C, D'Ambrogio G, Barreca A, et al: Relationship between human oocyte maturity, fertilization and follicular fluid growth factor. Hum Reprod 1994;9:902-906.
35. Lighten A, Moore G, Winston R, Hardy K: Routine addition of human insulin-like growth factor-I ligand could benefit clinical in-vitro fertilization culture. Hum Reprod 1998;13:3144-3150.
36. Irving JA, Lala PK: Function of cell surface on human integrin on human trophoblast cell migration: Regulation by TGF-β, IGFII and IGFBP1. Exp Cell Res 1995;217:419-427.
37. Irwin JC, de las Fuentas L, Duspin BA, Guidice LC: Insulin-like growth factor regulation of human endometrial stromal cell function. Coordinate effects on insulin-like growth factor binding protein I, cell proliferation and prolactin secretion. Regul Pept 1993;48:165-177.
38. Giudice LC, Martina NA, Crystal RA, et al: Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am J Obstet Gynecol 1997;176:751-757.
39. Han VK, Matsell DG, Delhanty PJ, Hill DJ, Shimasaki S, Nygard K: IGF-binding protein mRNAs in the human fetus: Tissue and cellular distribution of developmental expression. Horm Res 1996;45:160-166.
40. Raab G, Klagsbrun M: Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1997;1333:F179-F200.
41. Paria BC, Ma W, Tan J, Raja S, Das S, Dey S, Hogan BL: Cellular and molecular responses of the uterus to embryo implantation can be elicited by locally applied growth factors. Proc Natl Acad Sci USA 2001;98:1047-1052.
42. Yoo H-J, Barlow DH, Mardon MH: Temporal and spatial regulation of expression of heparin-binding epidermal growth factor-like growth factor in the human endometrium: A possible role in blastocyst implantation. Dev Genet 1997;21:102-108.
43. Leach RE, Khalifa R, Ramirez ND, Das SK, Wang J, Dey SK, Romero R, Armant DR: Multiple roles for heparin-binding epidermal growth factor-like growth factor are suggested by its cell-specific expression during the human endometrial cycle and early placentation. J Clin Endocrinol Metab 1999;84:3355-3363.
44. Das SK, Wang XN, Paria BC, Damm D, Abraham JA, Klagsbrun M, Andrews GK, Dey SK: Heparin-binding EGF-like growth factor is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: A possible ligand for interaction with blastocyst EGF receptor in implantation. Development 1994;120:1063-1071.
45. Wang J, Mayernik L, Schultz JF, Armant DR: Acceleration of trophoblast differentiation by heparin-binding EGF-like growth factor is dependent on the stage-specific activation of calcium influx by ErbB receptors in developing mouse blastocysts. Development 2000;127:33-44.
46. Tamada H, Higashiyama C, Takano H, Cohn J, Massey JB, Robinson J, Killick SR: The effect of heparin-binding epidermal growth factor-like growth factor on preimplantation-embryo development and implantation in the rat. Life Sci 1999;64:1967-1973.
47. Stavreus-Evers A, Aghajanova L, Brismar H, Eriksson H, Landgren BM, Hovatta O: Co-existence of heparin-binding epidermal growth factor-like growth factor and pinopodes in human endometrium at the time of implantation. Mol Hum Reprod 2002;8:765-769.
48. Martin KL, Barlow DH, Sargent IL: Heparin-binding epidermal growth factor significantly improves human blastocyst development and hatching in serum-free medium. Hum Reprod 1998;13:1645-1652.
49. Ozornek MH, Bielfeld P, Krussel JS, Hirchenhain J, Jeyendran RS, Koldovsky U: Epidermal growth factor and leukaemia inhibitory factor levels in follicular fluid. Association with in vitro fertilization outcome. J Reprod Med 1999;44:367-369.
50. Hilton DJ, Gough NM: Leukemia inhibitory factor: A biological perspective. J Cell Biochem 1991;46:21-26.
51. Hibi M, Nakajima K, Hirano T: IL-6 cytokines family and signal transduction: A model of the cytokine system. J Mol Med 1996;74:1-12.
52. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L: Interleukin 6-type cytokines signalling through the gp130/Jak/STAT pathway. Biochem J 1998;334:297-314.
53. Auernhammer CJ, Melmed S: Leukemia inhibitory factor neuroimmunomodulator of endocrine function. Endocr Rev 2000;21:313-345.
54. Nilsson EE, Kezele P, Skinner MK: Leukemia inhibitory factor (LIF) promotes the primordial to primary follicle transition in rate ovary. Mol Cell Endocrinol 2002;188:65-73.
55. Vogiagis D, Marsh MM, Fry RC: Leukaemia inhibitory factor in human endometrium throughout the menstrual cycle. J Endocrinol 1996;148:95-102.
56. Bhatt H, Brunet LJ, Stewart CL: Uterine expression of leukaemia inhibitory factor coincides with the onset of blastocyst implantation. Proc Natl Acad Sci USA 1991;88:11408-11412.
57. Heath JK: Cytokines. Can there be life without LIF. Nature 1992;359:17.
58. Yang ZM, Le SP, Chen DB, et al: Expression pattern of leukaemia inhibitory factor receptor (LIFR) and the gp 130 receptor component in rabbit uterus during early pregnancy. J Reprod Fertil 1996;2:249-255.
59. Lindhard A, Bentin-Ley U, Ravan V, et al: Biochemical evaluation of endometrial function a the time of implantation. Fertil Steril 2002;78:221-233
60. Arici A, Engin O, Attar E, Olive DL: Modulation of leukaemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrinol Metab 1995;80:1908-1915.
61. Senturk LM, Arici A: Leukaemia inhibitory factor in human reproduction. Am J Reprod Immunol 1998;39:144-151.
62. Tsuji Y, Tamaoki TH, Hasegawa A, Kashiwamura S, Iemoto A, Ueda H, et al: Expression of IL-18 and its receptor in mouse ovary. Am J Reprod Immunol 2001;46:349-357.
63. Dunglinson GF, Barlow DH, Sargent IL: Leukaemia inhibitory factor significantly enhances the blastocyst formation rates of human embryos cultured in serum-free medium. Hum Reprod 1996;11:191-196.
64. Nachtigall MJ, Kliman HJ, Feinberg RF, et al: The effect of leukaemia inhibitory factor (LIF) on trophoblast differentiation: A potential role in human implantation. J Clin Endocrinol Metab 1996;81:801-806.
65. Takabatake K, Fujiwara H, Goto Y, et al: Splenocytes in early pregnancy promote embryo implantation in mice. Hum Reprod 1997;12:2102-2107.
66. Stewart CL, Cullinan EB: Preimplantation development of the mammalian embryo and its regulation by growth factors. Dev Genet 1997;21:91-101.
67. Laird SM, Tuckerman EM, Dalton CF, Dunphy BC, Li TC, Zhang X: The production of leukaemia inhibitory factor by human endometrium: Presence in uterine flushings and production by cells in culture. Hum Reprod 1997;12:569-574.
68. Hambartsoumian E: Endometrial leukaemia inhibitory factor (LIF) as a possible cause of unexplained infertility and multiple failures of implantation. Am J Reprod Immunol 1998;39:137-143.
69. Delage G, Moreau JF, Taupin JF, Freitas S, Hambartsoumian E, Olivennes F, Fanchin R, Letur-Konirsch H, Frydmann R, Chaouat G: In vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant cultures from fertile and infertile women. Hum Reprod 1995;10:2483-2488.
70. Sherwin JRA, Smith SK, Wilson A, Sharkey AM: Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility. J Clin Endocrinol Metab 2002;87:3953-3960.
71. Chaouat G, Menu E, Delage G, Moreau FJ, Khrishnan L, et al: Immuno-endometrial interaction in early pregnancy. Hum Reprod 1995;10(suppl 2):55-59.
72. Ernst M, Inglese M, Waring P, et al: Defective gp130-mediated signal transducer and activator of transcription (STAT) signalling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med 2001;194:189-203.
73. Stewart CL, Kasper P, Brunet IJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo ST: Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992;359:76-79.
74. Nichols J, Davidson D, Taga T, Yoshida K, Chambers I, Smith A: Complementary tissue-specific expression of LIF and LIF receptor mRNA AS in early mouse embryogenesis. Mech Dev 1996;57:123-131.
75. Jean M, Mirallie S, Barriere P, et al: Leukaemia inhibitory factor expression in human follicular fluid. Hum Reprod 1997;14:571.
76. Arici A, Oral E, Bukulmez O, Buradagunta S, Bahtiyar O, Jones EE: Monocyte chemotactic protein-1 expression in human preovulatory follicles and ovarian cells. J Reprod Immunol 1997;32:201-219.
77. Lédéé-Bataille N, Laprée-Delage G, Taupin LJ, Dubanchet S, Taieb J, Moreau JF, Chaouat G: Follicular fluid concentration of leukaemia inhibitory factor is decreased among women with polycystic ovarian syndrome during assisted reproduction cycles. Hum Reprod 2001;16:2073-2078.
78. Lavranos TC, Rathjen PD, Seamark RF: Trophic effects of myeloid leukaemia inhibitory factor (LIF) on mouse embryos. J Reprod Fertil 1995;105:331-338.
79. Jurisicova A, Ben Chetrit A, Varmuza SL, Camper RF: Recombinant human leukemia inhibitory factor does not enhance in vitro human blastocyst formation. Fertil Steril 1995;64:999-1002.
80. Olivennes F, Ledee-Bataille N, Samama M, Kadoch J, Taupin JL, Dubanchet S, Chaouat G, Frydman R: Assessment of leukaemia inhibitory factor levels by uterine flushing at the time of egg retrieval does not adversely affect pregnancy rates with in vitro fertilization. Fertil Steril 2003;79:900-904.
81. Wu MY, Chen HF, Chen SU, Chao KH, Yang YS, Ho HN: Increase in the production of interleukin-10 early after implantation is related to the success of pregnancy. Am J Reprod Immunol 2001;46:386-392.
82. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
83. Ravindranath L, Little-Ihring LL, Phillips HS, et al: Vascular endothelial growth factor messenger ribonucleic acid expression in primate ovary. Endocrinology 1992;131:254-260.
84. Kamat BR, Brown LF, Manseau EJ, et al: Expression of VPF/VEGF by human granulosa and theca luteal cells: Role in corpus luteum development. Am J Pathol 1995; 146:157-165.
85. Van Blerom J, Antczak M, Schrader R: The development potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: Association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod 1997;12:1047-1055.
86. Van Blerkom J: Epigenetic influences on oocytes developmental competence: Perifollicular vascularity and intrafollicular oxygen. J Assist Reprod Genet 1998; 15:226-234.
87. Geva E, Jaffe RB: Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 2000;74:429-438.
88. Ferrara N, Chen H, Davis-Smyth T, Gerber HP, Nguyen TN, Peers D, et al: Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 1998;4:336-340.
89. Neulen J, Yan Z, Razek S, Weindel K, Keck C, Weich HA, Marme D, Breckwoldt M: Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: Importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 1995;80:1967-1971.
90. Christenson LK, Stouffer RL: Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cell from pre- and periovulatory follicles. J Clin Endocrinol Metab 1997;82:2135-2142.
91. Doldi N, Bassan M, Messa A, Ferrari A: Expression of vascular endothelial growth factor in human luteinizing granulosa cells and its correlation with the response to controlled ovarian hyperstimulation. Gynecol Endocrinol 1997;11:263-267.
92. Lee TH, Wu MY, Chen MJ, Chao KH, Ho HN, Yang YS: Nitric oxide is associated with poor embryo quality and pregnancy outcome in in vitro fertilization cycle. Fertil Steril 2004;82:126-131.
93. Barroso G, Barrionuevo M, Rao P, Graham L, Danforth D, Huey S, Abuhamad A, Ohninger S: Vascular endothial growth factor, nitric oxide, and leptin follicular fluid levels correlate negatively with embryo quality in IVF of IVF patients. Fertil Steril 1999;72:1024-1026.
94. Friedman CI, Argogast L, Danforth DR, et al: Follicular fluid vascular endothelial growth factor concentrations are elevated in women of advanced reproductive age undergoing ovulation induction. Fertil Steril 1997;68:607-612.
95. Manau D, Balash J, Jimenez W, Fabregues F, Civico S, Casamitjana R, Creus M, Vanrell JA: Follicular fluid concentration of adrenomedullin, vascular endothelial growth factor and nitic oxide in IVF cycle: Relationship to ovarian response. Hum Reprod 2000;15:1295-1299.
96. Benifla JL, Bringuier AF, Sifer C, Porcher R, Madelenatz P, Feldmann G: Vascular endothelial growth factor, platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 in follicular fluid of patients undergoing IVF. Hum Reprod 2001;16:1376-1381.
97. Ocal P, Aydin S, Cepni I, Idil S, Idil M, Uzun H, Benian A: Follicular fluid concentrations of vascular endothelial growth factor, inhibin A and inhibin B in IVF cycles: Are they markers for ovarian response and pregnancy outcome? Eur J Obstet Gynecol Reprod Biol 2004;115:194-199.
98. Evans PW, Wheeler T, Anthony FW, Osmond C: A longitudinal study of maternal serum vascular endothelial growth factor in early pregnancy. Hum Reprod 1998; 13:1057-1062.
99. Clark SC, Kamen R: The human hematopoietic colony stimulating factors. Science 1987;236:1229-1237.
100. Shiraishi S, Nakagawa K, Kinukawa N, Nakano H, Sueishi K: Immunohistochemical localization of vascular endothelial growth factor in the human placenta. Placenta 1996;17:111-121.
101. Yan Z, Weich HA, Bernart W, et al: Vascular endothelia growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cell in vitro. J Clin Endocrinol Metab 1993;77:1723-1725.
102. Elchelal U, Schenker JG: The pathophysiology of ovarian hyperstimulation syndrome. View and ideas. Hum Reprod 1997;12:1129-1137.
103. Felemban A, Sammour A, Tulandi T: Serum vascular endothelial growth factor as a possible marker for early ectopic pregnancy. Hum Reprod 2002;17:490-492.
104. Daniel Y, Geva E, Amit A, Baram A, Englender T, Kupferminc MJ, et al: Levels of soluble vascular cell adhesion molecules-1 and soluble intracellular adhesion molecules-1 are increased in women with ovarian hyperstimulation syndrome. Fertil Steril 1999;71:896-901.
105. Fasouliotis S, Spandorfer S, Witkin S, Liu HC, Roberts J, Rosenwaks Z: Maternal serum endothelial growth factor levels in early ectopic and intrauterine pregnancies after in vitro fertilization treatment. Fertil Steril 2004;82:309-313.
106. Graham CH, Lysiak JJ, McCrae KR, Lala PK: Localization of transforming growth factor at the human fetal-maternal interface: Role in trophoblast growth and differentiation. Biol Reprod 1992;4:561-572.
107. Selick CE, Horowitz GM, Gratch M, Scott RT, Navott D, Hoffmann GE: Immunohistochemical localization transforming growth factor beta in human implantation sites. J Clin Endocrinol Metab 1994;78:592-596.
108. Lysiak JJ, Han VKM, Lala PK: Localization of transforming growth factor alpha in the human placenta and deciduas: Role in trophoblast growth. Biol Reprod 1993;49:885-894.
109. Bruce-Mann G, Fowler KJ, Gabriel A, Nice EC, Linsay WR, Dunn AR: Mice with a null mutation of the TGF-gene have abnormal skin architecture, wavy hairs and curly whiskers and often develop corneal inflammation. Cell 1993;73:249-261.
110. Luetteke NC, Qui TH, Peiffer RL, Oliver P, Smithies O, Lee DC: TGF-deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 1993;73:263-278.
111. Fried G, Wramsby H: Increase in transforming growth factor beta1 in ovarian follicular fluid following ovarian hyperstimulation and in vitro fertilization correlates to pregnancy. Hum Reprod 1998;13:656-659.
112. Adash EY, Renick CE, Croft CS, May JV: Basic fibroblast growth factor as a regulator of ovarian granulosa cell differentiation: A novel non-mitogenic role. Mol Cell Endocrinol 1988;55:7-14.
113. Gospodarowicz D, Plouet J, Fujii DK: Ovarian germinal epithelial cells respond to basic fibroblast growth factor and express its gene: Implication for early folliculogenesis. Endocrinology 1989;125:1266-1276.
114. Seli E, Zeyneloglu H, Senturk L, Bahtiyar O, Olive D, Arici A: Basic fibroblast growth factor: Peritoneal and follicular fluid levels and its effect on early embryonic development. Fertil Steril 1998;69:1145-1148.
115. Hammadeh ME, Fischer-Hammadeh C, Hoffmeister H, Herrmann W, Georg T, Rosenbaum P, Schmidt W: Relationship between cytokine concentration (FGF, sICAM-1 and SCF) in serum, follicular fluid and ICSI outcome. Am J Reprod Immunol 2004;51:81-85.
116. Iwabe T, Harada T, Tsudo T, Nagano Y, Yoshida S, Tanikawa M, et al: Tumor necrosis factor-alpha promotes proliferation of endometriotic stromal cells by inducing interleukin-8 gene and protein expression. J Clin Endocrinol Metab 2000;85:824-829.
117. Nothnick WB: Treating endometriosis as an autoimmune disease. Fertil Steril 2001;76:223-231.
118. Wang LJ, Brannströrm M, Robertson SA, Norman RJ: Tumor necrosis factor alpha in the human ovary: Presence in follicular fluid and effects on cell proliferation and prostaglandin production. Fertil Steril 1992;58:934-940.
119. Spaczynski RZ, Arici A, Duleba AJ: Tumor necrosis factor-alpha stimulates proliferation of rat ovarian theca-interstitial cells. Biol Reprod 1999;61:993-998.
120. Tabibzadeh SS: Ubiquitous expression of TNFα/cachectin in human endometrium. Am J Reprod Immunol 1991;26:1-5.
121. Hunt JS, Chen HL, Hu XL, Tabibzadeh SS: Tumour necrosis factor messenger ribonucleic acid and protein in human endometrium. Biol Reprod 1992;47:141-147.
122. Philippaeaux MM, Piguet PF: Expression of tumour necrosis factor alpha and its mRNA in the endometrial mucosa during the menstrual cycle. Am J Pathol 1993;143:480-486.
123. Eades DK, Cornelins P, Pekala PH: Characterisation of the tumour necrosis factor receptor in human placenta. Placenta 1988;9:247-251.
124. So T, Ito A, Sato T, Mori Y, Hirakawa S: Tumour necrosis factor stimulates the biosynthesis of matrix metalloproteinase and plasminogen activator in cultured human chorionic cells. Biol Reprod 1992;46:772-778.
125. Brännström M, Friden BE, Jasper M, Norman RJ: Variation in peripheral blood levels of immunoreactive tumor necrosis factor alpha (TNFα) throughout the menstrual cycle and secretion of TNFα from the human corpus luteum. Eur J Obstet Gynecol Reprod Biol 1999;83:213-217.
126. Lee KS, Joo BSD, NA YJ, Yoon MS, Choi OH, Kim WW: Relationship between concentrations of tumour necrosis factor-alpha and nitric oxide in follicular fluid and oocyte quality. J Assist Reprod Genet 2000;17:222-228.
127. Baldwin GC: The biology of granulosa-macrophages colony-stimulating factor: Effect on hematopoietic and nonhematopoietic cells. Dev Biol 1992;151:352-367.
128. Imakawa K, Helmer S, Nephew K, Meka CS, Christenson PK: Enhancement of pregnancy specific interferon production, ovine trophoblast protein-1. Endocrinology 1993;132:1869-1871.
129. Robertson SA, Mayhofer G, Seamark R: Ovarian steroid hormones regulate granulocyte-macrophage colony-stimulating factor synthesis by uterine epithelial cells in the mouse. Biol Reprod 1996;54:183-196.
130. McKiernan SH, Bavister BD: Timing of development is a critical parameter for predicting successful embryogenesis. Hum Reprod 1994;9:2123-2129.
131. Sjöblom C, Wikland M, Robertson AA: Granulocyte-macrophage colony-stimulating factor promotes human blastocyst development in vitro. Hum Reprod 1999; 14:3069-3076.
132. Hammadeh ME, Ertan AK, Baltes S, Breamert B, Georg T, Rosenbaum P, Schmidt W: Association between interleukin concentration in follicular fluid and intracytoplasmic sperm injection (ICSI) outcome. Am J Reprod Immunol 2001;45:161-167.
133. Stanley ER, Heard PM: Factors regulating macrophage production and growth: Purification and some properties of the colony stimulating factor from medium conditioned by mouse L cells. J Biol Chem 1977;252:4305-4312.
134. Witt BR, Pollard JW: Colony stimulating factor-1 in human follicular fluid. Fertil Steril 1997;68:259-264.
135. Pollard JW, Hennighausen L: Colony stimulating factor 1 is required for mammary gland development during pregnancy. Proc Natl Acad Sci U A 1994;91:9312-9316.
136. Shinetugs B, Runesson E, Bonello NP, Brannstrom M, Norman RJ: Colony stimulating factor-1 concentrations in blood and follicular fluid during the human menstrual cycle and ovarian stimulation: Possible role in the ovulatory process. Hum Reprod 1999; 14:1302-1306.
137. Nishimura K, Tanaka N, Kawano T, et al: Changes in macrophage colony-stimulating factor concentration in serum and follicular fluid in vitro fertilization and embryo transfer cycles. Fertil Steril 1995;68:53-57.
138. Morstyn G, Burgess AW: Hemopoietic growth factors: A review. Cancer Res 1988;48:5624-5637.
139. Giacobini G, Tabibzadeh SS, Satyaswaroop PG, Bonsi L, Vitale L, Bagnara GP, et al: Epithelial cells are the major source of biologically active granulocyte macrophage colony stimulating factor in human endometrium. Hum Reprod 1995;10:3259-3263.
140. Stanley ER, Guilberts LJ, Tushinski RJ, et al: CSF-1. A mononuclear phagocyte lineage-specific hemopoietic growth factor. J Cell Biochem 1983;21:151-159.
141. McCracken AS, Grant KE, MacKenzie IZ, Redman CW, Pardon HJ: Gestational regulation of granulocyte colony-stimulating factor receptor expression in the human placenta. Biol Reprod 1999;60:790-796.
142. Uzumaki H, Okabe T, Sasaki N, Hagiwara K, Takaku F, Tobita M, et al: Identification and characterization of receptor for granulocyte colony-stimulating factor on human placenta and trophoblastic cells. Proc Natl Acad Sci USA 1989;86:9323-9326.
143. Pollard JW, Bartocci A, Arceci R, Orlofsky A, Ladner MB, Stanley ER: Apparent role of the macrophage growth factor, CSF-1, in placental development. Nature 1987;330:484-486.
144. Saji F, Azuma C, Kimura T, Koyama Y, Ohashi K, Tanizawa O: Gene expression of macrophage colony stimulating factor and its receptor in human placenta and deciduas. Am J Reprod Immunol 1990;24:99-104.
145. Beauchamp JL, Croy BA: Assessment of expression of the receptor for colony-stimulating factor-1 (fms) in bovine trophoblast. Biol Reprod 1991;45:811-817.
146. Yanagi K, Makinoda S, Fujii R, Miyazaki S, Fujita S, Tomizawa H, et al: Cyclic changes of granulocyte colony-stimulating factor (G-CSF) mRNA in the human follicle during the normal menstrual cycle and immunolocalization of G-CSGF protein. Hum Reprod 2002;17:3046-3052.
147. Hock DL, Huhn RD, Kemmann E: Leukocytosis in response to exogenous gonadotropin stimulation. Hum Reprod 1997;12:2143-2146.
148. Makinoda S, Mikuni M, Furuta I, Okuyama K, Sagawa T, Fujimoto S: Serum concentration of endogeneous G-CSF in women during the menstrual cycle and pregnancy. Eur J Clin Invest 1995;25:877-879.
149. Salmassi A, Schmutzler AG, Huang L, Hedderich J, Jonat W, Mettler L: Detection of granulosa colony-stimulating factor and its receptor in human follicular luteinized granulosa cells. Fertil Steril 2004;81:(suppl 1):789-791.
150. Kawano Y, Kawasaki F, Nakamura S, Matsui N, Narahara H, Miyakawa I: The production and clinical evaluation of macrophage colony-stimulating factor and macrophage chemoattractant protein-1 in human follicular fluids. Am J Reprod Immunol 2001;45:1-5.
151. Galli SJ, Zsebo KM, Geissler EN: The kit ligand, stem cell factor. Adv Immunol 1994;55:1-96.
152. Besmer P: The kit ligand encoded at the murine Steel locus: A pleiotropic growth and differentiation factor. Curr Opin Cell Biol 1991;3:939-946.
153. Parrott J, Skinner M: Kit-ligand/stem cell factor induces primordial follicle development and initiates folliculogenesis. Endocrinology 1999;140:4262-4271.
154. Horie K, Fujita J, Takakura K, Kanzaki H, Suginami H, Iwai M, et al: The expression of c-kit protein in human adult and fetal tissues. Hum Reprod 1993;8:1955-1962.
155. Laitinen M, Rutanen EM, Ritvos O: Expression of c-kit ligand messenger ribonucleic acids in human ovaries and regulation of their steady state levels by gonadotropins in cultured granulosa-luteal cells. Endocrinology 1995;136:4407-4414.
156. Bedell MA, Brannan CI, Evans EP, Copeland NG, Jenkins NA, Donava PJ: DNA rearrangements located over 100 kb 5′ of the Steel (SI)-coding region in Steel-panda and Steel-contrasted mice deregulate SI expression and cause female sterility by disrupting ovarian follicle development. Genes Dev 1995;9:455-470.
157. Smikle C, Dandekar P, Schriock E, Givens C: Elevated ovarian follicular fluid stem cell factor concentrations are associated with improved pregnancy rates in in vitro fertilization cycles. Fertil Steril 1998;69:70-72.